Literature DB >> 35575953

QT interval instability and variability in dogs with naturally-occurring hypercortisolism.

Beatriz de Carvalho Pato Vila1, Marcela Sigolo Vanhoni2, Marlos Gonçalves Sousa2.   

Abstract

Hypercortisolism is one of the most common endocrine diseases in dogs. In humans, it is clearly associated with a higher risk of cardiovascular events, but studies in dogs are scarce. To investigate the arrhythmogenic risk of dogs with naturally-occurring hypercortisolism (NOHC), indices of variability and instability of the QT interval were retrospectively studied in 38 dogs with NOHC and prospectively studied in 12 healthy dogs: variance (QTv), total instability (TI), short-term (STI) and long-term (LTI), and mean (QTm). Except for QTm, all parameters studied were higher in the NOHC group than in the control group. In addition, STI and QTv showed moderate positive correlation with left ventricle wall thickness. The NOHC group was subdivided according to cortisol suppression pattern in the low-dose dexamethasone suppression test. All electrocardiographic indices of partial and absent suppression patterns were numerically higher than healthy dogs. QTv and TI were lower in the control group than in both NOHC subgroups. LTI and STI were lower in the CG than in the group with the partial suppression pattern. There was no statistical difference between sex groups in any of the electrocardiographic parameters studied. This result might indicate that the etiology of NOHC, and its consequent influence on hypothalamus-pituitary-adrenal axis could interfere on the heterogeneity of ventricular repolarization parameters in different ways, especially in the short-term and the long-term stability; however further studies are necessary to understand the role of cortisol on electrical instability in dogs.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Arrhythmia; Cortisol; Cushing’s syndrome; Hyperadrenocorticism; QT variability

Year:  2022        PMID: 35575953     DOI: 10.1007/s11259-022-09936-1

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  54 in total

1.  Circadian profile of QT interval and QT interval variability in 172 healthy volunteers.

Authors:  Hendrik Bonnemeier; Uwe K H Wiegand; Wiebke Braasch; Axel Brandes; Gert Richardt; Jürgen Potratz
Journal:  Pacing Clin Electrophysiol       Date:  2003-01       Impact factor: 1.976

2.  Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study.

Authors:  Hilary F Armstrong; Gina S Lovasi; Elsayed Z Soliman; Susan R Heckbert; Bruce M Psaty; John H M Austin; Jerry A Krishnan; Eric A Hoffman; Craig Johnson; Matthew J Budoff; Karol E Watson; R Graham Barr
Journal:  Respir Med       Date:  2016-12-08       Impact factor: 3.415

Review 3.  Meta-analysis of left ventricular hypertrophy and sustained arrhythmias.

Authors:  Saurav Chatterjee; Chirag Bavishi; Partha Sardar; Vikram Agarwal; Parasuram Krishnamoorthy; Tomasz Grodzicki; Franz H Messerli
Journal:  Am J Cardiol       Date:  2014-07-18       Impact factor: 2.778

4.  QT instability, an indicator of augmented arrhythmogenesis, increases with the progression of myxomatous mitral valve disease in dogs.

Authors:  B C Brüler; F S Jojima; G Dittrich; A T Giannico; M G Sousa
Journal:  J Vet Cardiol       Date:  2018-07-18       Impact factor: 1.701

Review 5.  Drug-induced QT prolongation and proarrhythmia: an inevitable link?

Authors:  Kamran Ahmad; Paul Dorian
Journal:  Europace       Date:  2007-09       Impact factor: 5.214

Review 6.  A benefit-risk assessment of class III antiarrhythmic agents.

Authors:  Bente Brendorp; Oledyg Pedersen; Christian Torp-Pedersen; Naji Sahebzadah; Lars Køber
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology.

Authors:  Mathias Baumert; Alberto Porta; Marc A Vos; Marek Malik; Jean-Philippe Couderc; Pablo Laguna; Gianfranco Piccirillo; Godfrey L Smith; Larisa G Tereshchenko; Paul G A Volders
Journal:  Europace       Date:  2016-01-27       Impact factor: 5.214

8.  Evaluation of individual low-dose dexamethasone suppression test patterns in naturally occurring hyperadrenocorticism in dogs.

Authors:  Michael Bennaim; Robert E Shiel; Christopher Forde; Carmel T Mooney
Journal:  J Vet Intern Med       Date:  2018-03-02       Impact factor: 3.333

9.  Cushing's syndrome-an epidemiological study based on a canine population of 21,281 dogs.

Authors:  Gaia Carotenuto; Eleonora Malerba; Costanza Dolfini; Francesca Brugnoli; Pasquale Giannuzzi; Giovanni Semprini; Paolo Tosolini; Federico Fracassi
Journal:  Open Vet J       Date:  2019-02-15

Review 10.  THERAPY OF ENDOCRINE DISEASE: Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis.

Authors:  Irina Bancos; Fares Alahdab; Rachel K Crowley; Vasileios Chortis; Danae A Delivanis; Dana Erickson; Neena Natt; Massimo Terzolo; Wiebke Arlt; William F Young; M Hassan Murad
Journal:  Eur J Endocrinol       Date:  2016-07-22       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.